Clinical Trial Update: The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating whether enoxaparin reduces the incidence of deep vein thrombosis after electrophysiology studies and radiofrequency ablat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Enoxaparin sodium (Lovenox) (Enoxaparin sodium)

Snippet

Sponsor: Melbourne Health | Conditions: Deep Vein Thrombosis | Phase 4 | Status: TERMINATED